2019-Antibiograms - NMCSD and CAMP PENDLETON - Final.pdf
Anticoagulation Clinic How to.pdf
Asthma Pathway, Pediatric.pdf
Burn Management Pathway.pdf
Clinical Pathway Peds Vascular Access FINAL May 2021.pdf
Code White Final.pdf
DETOX Protocol FINAL.pdf
DKA HHS ED ICU Final 24FEB2020.pdf
ED 1.1 Thoracostomy.pdf
ED 1.2 Navy Low Risk Chest Pain 2017 update.pdf
ED 2.1 Skin and Soft Tissue Infections version2021.pdf
ED 2.2 Appendictis.pdf
ED 3.1 Pediatric Fever Without Source 0 to 60 days 3.1 (1).pdf
ED 3.1 Pediatric Fever Without Source 0 to 60 days 3.1.pdf
ED 3.1 Pneumonia update 2021.pdf
ED 4.2 Pediatric Fever Without Source 61 days-36 months 4.2 (1).pdf
ED 4.2 Pediatric Fever Without Source 61 days-36 months 4.2.pdf
ED 5.2 Low Dose Ketamine For Analgesia.pdf
ED 6.1 Intranasal Medication Guideline.pdf
ED 7.1 Adult Asthma Pathway.pdf
ED 8.1 Neonatal and Pediatric Sepsis Guideline (1).pdf
ED 9.2 Kidney Stone.pdf
ED 10.2 Pain Management.pdf
ED 11.1 Atrial Fibrillation Guideline.pdf
ED 12.2 Venous Thromboembolic Disease.pdf
ED 13.1 Anticoagulation Reversal.pdf
ED 14.1 Adult Febrile Neutropenia.pdf
ED 15.1 Subarachnoid Hemorrhage.pdf
ED 16.1 Push Dose Pressors.pdf
ED COVID Therapeutics Treatment Plan version 1.28.pdf
Lipid Emulsion Treatment for Local Anesthetic Systemic Toxicity.pdf
NMCSD Post-Exposure Prophylaxis updated 2022.pdf
NMCSD Adult Antibiotic Reference 2018.pdf
NMCSD Pediatric Antibiotic Reference 2018.pdf
Pediatric And Adult Influenza Treatment Algorithm (2021-2022).pdf
Rivaroxaban ED Pathway.pdf